Selected research
Industry Research
Cancer Biopsy Instruments and Kits Industry Research Report 2026
Market perspective
The global Cancer Biopsy Instruments and Kits market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cancer Biopsy Instruments and Kits is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cancer Biopsy Instruments and Kits is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cancer Biopsy Instruments and Kits include QIAGEN NV, ANGLE plc, Becton, Dickinson and Company, BIOCEPT, INC., Danaher Corporation, Hologic, Inc., Illumina, Inc., Lucence Diagnostics Pte. Ltd. and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cancer Biopsy Instruments and Kits market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cancer Biopsy Instruments and Kits Market by Company
QIAGEN NV
ANGLE plc
Becton, Dickinson and Company
BIOCEPT, INC.
Danaher Corporation
Hologic, Inc.
Illumina, Inc.
Lucence Diagnostics Pte. Ltd.
Myriad Genetics
Thermo Fisher Scientific, Inc.
Cancer Biopsy Instruments and Kits Segment by Type
Cancer Biopsy Instruments
Cancer Biopsy Kits
Cancer Biopsy Instruments and Kits Segment by Application
Breast Cancer
Colorectal Cancer
Cervical Cancer
Lung Cancer
Others
Cancer Biopsy Instruments and Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Biopsy Instruments and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Biopsy Instruments and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Biopsy Instruments and Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cancer Biopsy Instruments and Kits by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cancer Biopsy Instruments and Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cancer Biopsy Instruments
- Cancer Biopsy Kits
Applications
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Others
Companies covered
- QIAGEN NV
- ANGLE plc
- Becton, Dickinson and Company
- BIOCEPT, INC.
- Danaher Corporation
- Hologic, Inc.
- Illumina, Inc.
- Lucence Diagnostics Pte. Ltd.
- Myriad Genetics
- Thermo Fisher Scientific, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cancer Biopsy Instruments and Kits Market Size (2021-2032)
- 2.2.2 Global Cancer Biopsy Instruments and Kits Sales (2021-2032)
- 2.2.3 Global Cancer Biopsy Instruments and Kits Market Average Price (2021-2032)
- 2.3 Cancer Biopsy Instruments and Kits by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cancer Biopsy Instruments
- 2.3.3 Cancer Biopsy Kits
- 2.4 Cancer Biopsy Instruments and Kits by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Colorectal Cancer
- 2.4.4 Cervical Cancer
- 2.4.5 Lung Cancer
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cancer Biopsy Instruments and Kits Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cancer Biopsy Instruments and Kits Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Cancer Biopsy Instruments and Kits Revenue of Manufacturers (2021-2026)
- 3.4 Global Cancer Biopsy Instruments and Kits Average Price by Manufacturers (2021-2026)
- 3.5 Global Cancer Biopsy Instruments and Kits Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cancer Biopsy Instruments and Kits, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cancer Biopsy Instruments and Kits, Product Type & Application
- 3.8 Global Manufacturers of Cancer Biopsy Instruments and Kits, Established Date
- 3.9 Global Cancer Biopsy Instruments and Kits Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 QIAGEN NV
- 4.1.1 QIAGEN NV Company Information
- 4.1.2 QIAGEN NV Business Overview
- 4.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
- 4.1.5 QIAGEN NV Recent Developments
- 4.2 ANGLE plc
- 4.2.1 ANGLE plc Company Information
- 4.2.2 ANGLE plc Business Overview
- 4.2.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
- 4.2.5 ANGLE plc Recent Developments
- 4.3 Becton, Dickinson and Company
- 4.3.1 Becton, Dickinson and Company Company Information
- 4.3.2 Becton, Dickinson and Company Business Overview
- 4.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
- 4.3.5 Becton, Dickinson and Company Recent Developments
- 4.4 BIOCEPT, INC.
- 4.4.1 BIOCEPT, INC. Company Information
- 4.4.2 BIOCEPT, INC. Business Overview
- 4.4.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
- 4.4.5 BIOCEPT, INC. Recent Developments
- 4.5 Danaher Corporation
- 4.5.1 Danaher Corporation Company Information
- 4.5.2 Danaher Corporation Business Overview
- 4.5.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
- 4.5.5 Danaher Corporation Recent Developments
- 4.6 Hologic, Inc.
- 4.6.1 Hologic, Inc. Company Information
- 4.6.2 Hologic, Inc. Business Overview
- 4.6.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
- 4.6.5 Hologic, Inc. Recent Developments
- 4.7 Illumina, Inc.
- 4.7.1 Illumina, Inc. Company Information
- 4.7.2 Illumina, Inc. Business Overview
- 4.7.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
- 4.7.5 Illumina, Inc. Recent Developments
- 4.8 Lucence Diagnostics Pte. Ltd.
- 4.8.1 Lucence Diagnostics Pte. Ltd. Company Information
- 4.8.2 Lucence Diagnostics Pte. Ltd. Business Overview
- 4.8.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
- 4.8.5 Lucence Diagnostics Pte. Ltd. Recent Developments
- 4.9 Myriad Genetics
- 4.9.1 Myriad Genetics Company Information
- 4.9.2 Myriad Genetics Business Overview
- 4.9.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
- 4.9.5 Myriad Genetics Recent Developments
- 4.10 Thermo Fisher Scientific, Inc.
- 4.10.1 Thermo Fisher Scientific, Inc. Company Information
- 4.10.2 Thermo Fisher Scientific, Inc. Business Overview
- 4.10.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
- 4.10.5 Thermo Fisher Scientific, Inc. Recent Developments
5 Global Cancer Biopsy Instruments and Kits Market Scenario by Region
- 5.1 Global Cancer Biopsy Instruments and Kits Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cancer Biopsy Instruments and Kits Sales by Region: 2021-2032
- 5.2.1 Global Cancer Biopsy Instruments and Kits Sales by Region: 2021-2026
- 5.2.2 Global Cancer Biopsy Instruments and Kits Sales by Region: 2027-2032
- 5.3 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2021-2032
- 5.3.1 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2021-2026
- 5.3.2 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2027-2032
- 5.4 North America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
- 5.4.1 North America Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
- 5.4.3 North America Cancer Biopsy Instruments and Kits Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
- 5.5.1 Europe Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
- 5.5.3 Europe Cancer Biopsy Instruments and Kits Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cancer Biopsy Instruments and Kits Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
- 5.7.1 South America Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
- 5.7.3 South America Cancer Biopsy Instruments and Kits Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cancer Biopsy Instruments and Kits Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
- 6.1.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2032)
- 6.2 Global Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
- 6.2.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2032)
- 6.3 Global Cancer Biopsy Instruments and Kits Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
- 7.1.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2032)
- 7.2 Global Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
- 7.2.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2032)
- 7.3 Global Cancer Biopsy Instruments and Kits Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cancer Biopsy Instruments and Kits Value Chain Analysis
- 8.1.1 Cancer Biopsy Instruments and Kits Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cancer Biopsy Instruments and Kits Production Mode & Process
- 8.2 Cancer Biopsy Instruments and Kits Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cancer Biopsy Instruments and Kits Distributors
- 8.2.3 Cancer Biopsy Instruments and Kits Customers
9 Global Cancer Biopsy Instruments and Kits Analyzing Market Dynamics
- 9.1 Cancer Biopsy Instruments and Kits Industry Trends
- 9.2 Cancer Biopsy Instruments and Kits Industry Drivers
- 9.3 Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges
- 9.4 Cancer Biopsy Instruments and Kits Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst